XRP traded at $1.4413 on Binance as of March 18, 2026, after a sharp reversal from a multi-day rally high near $1.62, with price now testing the 50-period SMA andXRP traded at $1.4413 on Binance as of March 18, 2026, after a sharp reversal from a multi-day rally high near $1.62, with price now testing the 50-period SMA and

XRP Pulls Back to $1.44 After Hitting $1.62: A Wedge Pattern Now Controls the Next Move

2026/03/19 00:51
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

XRP traded at $1.4413 on Binance as of March 18, 2026, after a sharp reversal from a multi-day rally high near $1.62, with price now testing the 50-period SMA and a developing wedge structure that analysts say will determine the next directional move.

What the 4-Hour Chart Shows

The chart covers the March 12 to March 18 period on the XRP/USDT pair, 4-hour timeframe, Binance. Price action from left to right tells a clean story.

XRP traded in a compressed range between roughly $1.38 and $1.42 through March 12 and into March 13, with the 50 SMA sitting below price and volume bars relatively subdued. A breakout initiated around March 14, with a series of green candles pushing price through $1.45 and into the $1.50 range by March 15. The rally extended further into March 16 and peaked on March 17 with a wick reaching approximately $1.62 – the highest point visible on the chart.

The reversal from that peak was sharp. A sequence of large red candles from March 17 into March 18 brought price back down to $1.4413 at the time of capture. The most recent candle on the right side of the chart is a large red body closing near the 50 SMA, which sits at $1.4337. Price is now approximately 0.5% above that moving average.

Volume during the selloff is visible in the pink bars on the volume panel, with a notable spike accompanying the March 18 decline. The current 4-hour volume reads 5.07 million XRP.

The RSI Divergence

The RSI panel below the price chart shows two lines. The purple line, the faster signal, has dropped sharply to 42.58 – below the midpoint and approaching oversold territory. The yellow line, the slower signal, remains elevated at 66.09, still reflecting the strength of the prior rally.

Bitcoin Drops to $72,000 Ahead of Federal Reserve Interest Rate Decision

That gap between the two readings is the key observation. The faster RSI has corrected aggressively while the slower one has not. That divergence is consistent with a sharp short-term pullback within a structure that has not fully reversed on a longer timeframe basis. It does not confirm a bottom. It suggests the selling pressure has been rapid rather than sustained.

The Wedge Structure

Crypto trader GainMuse published a broader technical read on XRPUSDT using a weekly or multi-week timeframe. The chart identifies a falling wedge pattern forming after an extended selloff, with price compressing between a descending resistance line and a rising support trendline.

Falling wedges are typically treated as bullish continuation or reversal structures. The thesis here is that selling pressure is fading as price coils between the two converging trendlines. A decisive bounce from the ascending support line, which aligns with current price levels on the longer timeframe, would signal the recovery scenario is intact.

The invalidation level is the support trendline itself. A break below it cancels the wedge structure and removes the technical basis for the recovery argument. GainMuse did not specify a numeric invalidation level in the published note.

Current price at $1.4413 sits roughly 11% below the March 17 peak and approximately 0.5% above the 50 SMA. The resistance line identified in the wedge analysis sits in the $1.80 to $1.85 range based on the chart geometry, representing a potential move of roughly 25% from current levels if the pattern resolves to the upside.

That upside scenario depends entirely on the support trendline holding. It has not been confirmed yet.

The post XRP Pulls Back to $1.44 After Hitting $1.62: A Wedge Pattern Now Controls the Next Move appeared first on ETHNews.

Market Opportunity
Ucan fix life in1day Logo
Ucan fix life in1day Price(1)
$0.0002952
$0.0002952$0.0002952
-1.13%
USD
Ucan fix life in1day (1) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26